| Similar Articles |
|---|
 |
The Motley Fool
March 31, 2008
Rich Duprey |
Foolish Forecast: Immucor's Draining Acquisition In advance of earnings, analysts expect blood-tester Immucor to continue to grow sales and profits, in spite of short-term expenses.   |
The Motley Fool
November 6, 2007
Billy Fisher |
Earnings Soar, Uncertainty Looms at WellCare Third-quarter revenue rises 41.7%, but investigations by state and federal agencies continue to make for an uncertain future. |
The Motley Fool
April 29, 2008
Brian Lawler |
Sciele's Blue-Moon Buyback The specialty pharmaceutical surprisingly renews its share repurchase plan. |
The Motley Fool
August 12, 2010
Jordan DiPietro |
7 Burned-Out Drug Stocks These 5-star drug stocks have been beaten down to attractive levels. |
The Motley Fool
February 16, 2007
Billy Fisher |
WellCare's Winning Record Ignoring downgrades, investors laud the healthcare company's success. |
The Motley Fool
May 8, 2007
Billy Fisher |
WellCare Bucks the Experts The managed-care company reports a strong quarter after several downgrades. Investors, take note. |
The Motley Fool
January 2, 2007
Rich Duprey |
Foolish Forecast: Bloody Good Showing for Immucor This blood-testing company's in a growth stage, but is it the right time to buy shares? |
The Motley Fool
April 5, 2007
Billy Fisher |
Another Boost for Immucor Since trading for pennies a share in 2001, shares of Immucor have been on a blistering pace. After the release of the company's third-quarter earnings recently, there's no apparent letup in sight, either. |
The Motley Fool
December 16, 2011
Seth Jayson |
Fool Cheat Sheet: FedEx Earnings For the quarter ended Nov. 30, FedEx met expectations on revenues and beat them on EPS. Margins improved across the board. |
The Motley Fool
December 16, 2011
Seth Jayson |
CIENA Whiffs on Earnings CIENA reported revenue of $455 million. The 19 analysts polled by S&P Capital IQ wanted to see revenue of $450 million. |
The Motley Fool
July 13, 2011 |
Immucor Earnings Preview After beating estimates last quarter by 5 cents, Immucor has set the standard for itself this Monday, July 18. |
The Motley Fool
December 16, 2011
Seth Jayson |
Fool Cheat Sheet: Accenture Earnings Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Accenture is outperform, with an average price target of $62.79. |
The Motley Fool
December 16, 2011
Seth Jayson |
Fool Cheat Sheet: Adobe Systems Earnings Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Adobe Systems is outperform, with an average price target of $31.19. |
The Motley Fool
December 19, 2011
Seth Jayson |
Costco Beats on Revenue, Matches Expectations on EPS For the quarter ended Nov. 20, Costco beat expectations slightly on revenues and met them on EPS. Margins contracted across the board. |
The Motley Fool
December 19, 2011
Seth Jayson |
Research In Motion's Horrible Quarter The info you need, the way you need it. |
The Motley Fool
October 4, 2007
Billy Fisher |
Immucor Draws First Blood The blood-testing equipment maker sees double-digit growth in both sales and earnings in Q1. |
The Motley Fool
December 22, 2009
Toby Shute |
The Search for the Next See's Candies Three serious small cap stocks for your consideration: Immucor... Balchem... Cass Information Systems... |
The Motley Fool
April 24, 2009 |
3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: United States Natural Gas Fund, LP... Campbell Soup Company... Immucor, Inc. ... |
The Motley Fool
July 16, 2007
Billy Fisher |
A Healthy Direction for WellCare The insurer's share price climbs after an analyst's upgrade. |
The Motley Fool
January 10, 2012
Alexander Crawford |
Deutsche Analyst Expects Q4 Earnings to Surprise: 10 Companies to Watch Do you think these stocks will surprise the market once more? |
The Motley Fool
October 1, 2010
Rick Aristotle Munarriz |
7 Reasons to Worry About Next Week Let's go over a few of the names that aren't getting the job done on the bottom line, going by what analysts believe they will report next week: Acuity Brands... Constellation Brands... Immucor... RPM... AngioDynamics... Int'l Speedway... Monsanto... |
The Motley Fool
December 19, 2011
Seth Jayson |
Cooper Companies Crushes Estimates For the quarter ended Oct. 31, Cooper Companies met expectations on revenues and crushed them on EPS. Gross margins increased, operating margins contracted, and net margins widened. |
The Motley Fool
June 29, 2009
Dave Mock |
A Big Upgrade for WellCare Health Plans This bullish call comes from more than just one analyst. More top-performing Motley Fool CAPS members are feeling bullish about WellCare Health Plans. |
The Motley Fool
October 6, 2006
Brian Lawler |
No Bloodbath at Immucor The company appears right on track for double-digit revenue growth. Investors, it is worth watching to see how Immucor copes with the retirement of its CEO last month, but most likely everything should proceed as normal. |
